List of Crestor drug patents

Crestor is owned by Ipr.

Crestor contains Rosuvastatin Calcium.

Crestor has a total of 1 drug patent out of which 1 drug patent has expired.

Expired drug patents of Crestor are:

  • US6858618*PED

Crestor was authorised for market use on 12 August, 2003.

Crestor is available in tablet;oral dosage forms.

The generics of Crestor are possible to be released after 27 May, 2023.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).


IPR Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia
Jun, 2022

(11 months ago)

Do you want to check out CRESTOR patents from before 2022?
Exclusivity Exclusivity Expiration
Orphan Drug Exclusivity (ODE) May 27, 2023

Drugs and Companies using ROSUVASTATIN CALCIUM ingredient

Market Authorisation Date: 12 August, 2003

Treatment: NA


How can I launch a generic of CRESTOR before it's patent expiration?
More Information on Dosage

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic